In this issue:
Testosterone therapy after definitive treatment for localised disease
Focal vs whole gland ablation effects on sexual function and urinary continence
Clinical significance of multiple negative surveillance prostate biopsies
Pan-AKT inhibitor capivasertib with docetaxel and prednisolone in mCRPC
Prostate radiotherapy with adjuvant vs neoadjuvant ADT
Patterns of cancer progression of metastatic hormone-sensitive prostate cancer
Ipilimumab after radiotherapy post-docetaxel in mCRPC
Functional recovery after modified RALP
Please login below to download this issue (PDF)